Cargando…

Autoantibodies as potential biomarkers for breast cancer

INTRODUCTION: Only a limited number of tumor markers for breast cancer are currently available. Antibodies to tumor-associated proteins may expand the number of available tumor markers for breast cancer and may be used together in a serum profile to enhance sensitivity and specificity. METHODS: In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Li, Ge, Kun, Zu, Jin-chi, Zhao, Long-hua, Shen, Wei-ke, Wang, Jian-fei, Zhang, Xiao-gang, Gao, Xu, Hu, Wanping, Yen, Yun, Kernstine, Kemp H
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481487/ https://www.ncbi.nlm.nih.gov/pubmed/18460216 http://dx.doi.org/10.1186/bcr2091

Ejemplares similares

Identification of Novel Autoantibodies for Detection of Malignant Mesothelioma
por: Zhang, Xufei, et al.
Publicado: (2013)

Protein microarray: sensitive and effective immunodetection for drug residues
por: Zhong, Li, et al.
Publicado: (2010)

Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
por: Yang, Ruozhu, et al.
Publicado: (2022)

Autoantibodies as Potential Biomarkers in Breast Cancer
por: Qiu, Jingyi, et al.
Publicado: (2018)

Combined Robotic Lobectomy and Adrenalectomy for Lung Cancer and Solitary Adrenal Metastasis
por: Yuh, Bertram, et al.
Publicado: (2012)

Autoantibody Biomarkers in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2020)

Autoantibodies in COVID-19: frequency and function
por: Gao, Zhao-wei, et al.
Publicado: (2021)

Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
por: Chen, Zhenbin, et al.
Publicado: (2009)

BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma
por: Tong, Yong-Qing, et al.
Publicado: (2011)

A novel autoantibody test for the detection of pre-neoplastic lung lesions
por: Lowe, Frazer J, et al.
Publicado: (2014)

Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer
por: Chung, Jee Min, et al.
Publicado: (2018)

Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray: Screening of autoantibodies in renal cancer
por: Sun, Yangyang, et al.
Publicado: (2022)

The 64-Multislice Computed Tomogram Averts Misdiagnosis of an Anomalous Origin of the Left Main Coronary Artery
por: Jebelli, Mohammad, et al.
Publicado: (2009)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Sputum Autoantibodies Are More Relevant in Autoimmune Responses in Asthma than Are Serum Autoantibodies
por: Qin, Rundong, et al.
Publicado: (2019)

Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer
por: Duan, Yaru, et al.
Publicado: (2022)

Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012)

Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases
por: Do, Le-Duy, et al.
Publicado: (2021)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
por: Dai, Liping, et al.
Publicado: (2013)

Upfront Brain Treatments Followed by Lung Surgery Improves Survival for Stage IV Non-small Cell Lung Cancer Patients With Brain Metastases: A Large Cohort Analysis
por: He, Xiaopeng, et al.
Publicado: (2021)

Are sputum autoantibodies more clinically relevant in idiopathic pulmonary fibrosis than serum autoantibodies?
por: Deng, Kuimiao, et al.
Publicado: (2022)

Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the National Cancer Database
por: MacLean, Matthew, et al.
Publicado: (2018)

Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases
por: Kocurova, Gabriela, et al.
Publicado: (2022)

Serum Autoantibody Biomarkers for Management of Rheumatoid Arthritis Disease
por: Sánchez-Tirado, Esther, et al.
Publicado: (2023)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

Staining Pattern Classification of Antinuclear Autoantibodies Based on Block Segmentation in Indirect Immunofluorescence Images
por: Li, Jiaqian, et al.
Publicado: (2014)

A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)
por: Bepler, Gerold, et al.
Publicado: (2014)

Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis
por: Fernández Madrid, Félix, et al.
Publicado: (2015)

Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma
por: SHAO, QING, et al.
Publicado: (2012)

Autoantibodies to Tumor-Associated Antigens in Breast Carcinoma
por: Piura, Ettie, et al.
Publicado: (2010)

Use of Autoantibodies to Detect the Onset of Breast Cancer
por: Lacombe, Jérôme, et al.
Publicado: (2014)

Measuring serum human epididymis secretory protein autoantibody as an early biomarker of lung cancer
por: Yang, Bin, et al.
Publicado: (2020)

Correction: Staining Pattern Classification of Antinuclear Autoantibodies Based on Block Segmentation in Indirect Immunofluorescence Images
por: Li, Jiaqian, et al.
Publicado: (2020)

Pulmonary paraganglioma in a 10-year-old: a case report and review of the literature
por: Geoffrion, Tracy R, et al.
Publicado: (2018)

Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care quality?
por: von Itzstein, Mitchell S., et al.
Publicado: (2020)

Elevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with Thrombocytopenia
por: Hu, Ya-Hui, et al.
Publicado: (2015)

From rheumatic diseases to cancer - role of autoantibodies as diagnostic biomarkers
por: Tan, Eng M
Publicado: (2012)

Novel Prostate Cancer Biomarkers Derived from Autoantibody Signatures()
por: Schipper, Matthew, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4h6ajpmnegcuuu5s8dgjj10j0d